Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection

Fig. 5

Correlation between the initial levels of evaluation value and stage, and the initial levels of evaluation value and pathology. A No significant differences were seen between stage I–II and III–IV. B No significant differences were seen among patients with well, moderate, and poorly differentiated adenocarcinoma. C Dynamic changes in evaluation value following surgery. The evaluation value with sDNA tests and FIT of 20 CRC patients decreased dramatically a month after resection

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us